Login
$CBOE
$335.25 -$5.17 (1.52%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Financial investments
Accounts receivable, net of $5.4 allowance for credit losses at June 30, 2026 and $6.8 at December 31, 2025
Margin deposits, clearing funds, and interoperability funds
Digital assets - safeguarded assets
Margin deposits, default fund, and interoperability fund
Income taxes receivable
Assets held for sale
Other current assets (includes restricted cash of $28.4 at June 30, 2026 and $34.1 at December 31, 2025)
Total current assets
Investments
Property held for sale
Property and equipment, net
Operating lease right of use assets
Goodwill
Intangible assets, net
Other assets, net
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities
Current portion of long-term debt
Section 31 fees payable
Deferred revenue
Margin deposits, clearing funds, and interoperability funds
Digital assets - safeguarded liabilities
Margin deposits, default fund, and interoperability fund
Income taxes payable
Current portion of contingent consideration liabilities
Liabilities held for sale
Total current liabilities
Long-term debt
Non-current unrecognized tax benefits
Deferred income taxes
Non-current operating lease liabilities
Non-current portion of contingent consideration liabilities
Other non-current liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.01 par value: 20,000,000 shares authorized, no shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.01 par value: 325,000,000 shares authorized, 104,944,263 and 104,554,843 shares issued and outstanding, respectively at June 30, 2026 and 104,654,764 and 104,647,739 shares issued and outstanding, respectively at December 31, 2025
Common stock in treasury, at cost: 389,420 shares at June 30, 2026 and 7,025 shares at December 31, 2025
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income, net
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support